First American Trust’s Gilead Sciences GILD Stock Holding History

First American Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$289K	Buy	2,072 +64	+3%	+$8.96K	0.02%	239
2025 Q4	$246K	Buy	2,008 +193	+11%	+$23.5K	0.02%	249
2025 Q3	$201K	Buy	+1,815	New	+$206K	0.01%	243
2020 Q4	–	Sell	-3,627	Closed	-$229K	–	156
2020 Q3	$229K	Sell	3,627 -36,870	-91%	-$2.56M	0.04%	128
2020 Q2	$3.12M	Buy	40,497 +3,179	+9%	+$244K	0.61%	62
2020 Q1	$2.79M	Buy	+37,318	New	+$2.58M	0.68%	54
2016 Q4	–	Sell	-3,276	Closed	-$259K	–	112
2016 Q3	$259K	Sell	3,276 -27,156	-89%	-$2.21M	0.08%	98
2016 Q2	$2.54M	Sell	30,432 -2,500	-8%	-$222K	0.9%	51
2016 Q1	$3.02M	Sell	32,932 -10,639	-24%	-$959K	1.06%	44
2015 Q4	$4.41M	Buy	43,571 +548	+1%	+$57K	1.62%	24
2015 Q3	$4.22M	Sell	43,023 -304	-0.7%	-$33.8K	1.63%	21
2015 Q2	$5.07M	Sell	43,327 -2,213	-5%	-$242K	1.88%	15
2015 Q1	$4.47M	Buy	45,540 +22	+0%	+$2.23K	1.59%	23
2014 Q4	$4.29M	Sell	45,518 -2,525	-5%	-$261K	1.59%	23
2014 Q3	$5.11M	Sell	48,043 -10,009	-17%	-$980K	1.9%	12
2014 Q2	$4.81M	Sell	58,052 -66	-0.1%	-$5.14K	1.83%	15
2014 Q1	$4.12M	Sell	58,118 -568	-1%	-$44.5K	1.54%	24
2013 Q4	$4.41M	Sell	58,686 -9,534	-14%	-$664K	1.49%	20
2013 Q3	$4.29M	Buy	68,220 +18,498	+37%	+$1.11M	1.54%	21
2013 Q2	$2.55M	Buy	+49,722	New	+$2.59M	0.96%	43

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

First American Trust's GILD Position: Q1 2026 in Review

First American Trust increased its Gilead Sciences (GILD) stake by 3.2% in Q1 2026, buying an estimated $8.96K and bringing the position to 2,072 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #239.

First American Trust first reported a position in GILD in Q2 2013 and has held it in 20 quarters since. The position peaked at $5.11M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

First American Trust held 2,072 shares of Gilead Sciences worth $289K as of Q1 2026.
First American Trust bought 64 Gilead Sciences shares in Q1 2026, an estimated $8.96K.
Gilead Sciences made up 0.02% of First American Trust's portfolio in Q1 2026, its #239 holding.
First American Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 20 quarters since.
First American Trust's Gilead Sciences position peaked at $5.11M in Q3 2014.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.